Cytek Biosciences, Inc. Common Stock CTKB

$4.05 -3.34% at last close
Market Cap$541.11 million
P/E Ratio
Div Yield
Volume706.6K
52-Week Range $2.37$6.18

Key Stats

Today's Range
$4.02 $4.19
50-Day Range
$3.31 $4.99
52-Week Range
$2.37 $6.18
Volume
707K shs
Average Volume
932K shs
Market Cap
$541.11 million
P/E Ratio
Dividend Yield

Valuation

P/E Ratio
Price / Book
1.65
Price / Sales
2.65

Short Interest

Short Interest
0.01%
Days to Cover
1.00

Financials (TTM)

Revenue
$204.17 million
Net Income
$-74,003,000
Net Margin
-36.25%
Return on Equity
-22.59%
Debt-to-Equity

About Cytek Biosciences, Inc. Common Stock

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Sector
LABORATORY ANALYTICAL INSTRUMENTS
Employees
702
Exchange
XNAS
Listed
2021-07-23

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.